Literature DB >> 24793995

Disrupting the male germ line to find infertility and contraception targets.

Denise R Archambeault1, Martin M Matzuk2.   

Abstract

Genetically-manipulated mouse models have become indispensible for broadening our understanding of genes and pathways related to male germ cell development. Until suitable in vitro systems for studying spermatogenesis are perfected, in vivo models will remain the gold standard for inquiry into testicular function. Here, we discuss exciting advances that are allowing researchers faster, easier, and more customizable access to their mouse models of interest. Specifically, the trans-NIH Knockout Mouse Project (KOMP) is working to generate knockout mouse models of every gene in the mouse genome. The related Knockout Mouse Phenotyping Program (KOMP2) is performing systematic phenotypic analysis of this genome-wide collection of knockout mice, including fertility screening. Together, these programs will not only uncover new genes involved in male germ cell development but also provide the research community with the mouse models necessary for further investigations. In addition to KOMP/KOMP2, another promising development in the field of mouse models is the advent of CRISPR (clustered regularly interspaced short palindromic repeat)-Cas technology. Utilizing 20 nucleotide guide sequences, CRISPR/Cas has the potential to introduce sequence-specific insertions, deletions, and point mutations to produce null, conditional, activated, or reporter-tagged alleles. CRISPR/Cas can also successfully target multiple genes in a single experimental step, forgoing the multiple generations of breeding traditionally required to produce mouse models with deletions, insertions, or mutations in multiple genes. In addition, CRISPR/Cas can be used to create mouse models carrying variants identical to those identified in infertile human patients, providing the opportunity to explore the effects of such mutations in an in vivo system. Both the KOMP/KOMP2 projects and the CRISPR/Cas system provide powerful, accessible genetic approaches to the study of male germ cell development in the mouse. A more complete understanding of male germ cell biology is critical for the identification of novel targets for potential non-hormonal contraceptive intervention.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Keywords:  CRISPR-Cas; Cellule germinale; Contraception; Germ cell; Infertility; Infertilité; KOMP; KOMP2; Spermatogenesis; Spermatogenèse

Mesh:

Substances:

Year:  2014        PMID: 24793995     DOI: 10.1016/j.ando.2014.04.006

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  8 in total

1.  Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells.

Authors:  Karen M Chapman; Gerardo A Medrano; Priscilla Jaichander; Jaideep Chaudhary; Alexandra E Waits; Marcelo A Nobrega; James M Hotaling; Carole Ober; F Kent Hamra
Journal:  Cell Rep       Date:  2015-03-12       Impact factor: 9.423

Review 2.  Non-hormonal male contraception: A review and development of an Eppin based contraceptive.

Authors:  Michael G O'Rand; Erick J R Silva; Katherine G Hamil
Journal:  Pharmacol Ther       Date:  2015-11-22       Impact factor: 12.310

Review 3.  Advantages of using the CRISPR/Cas9 system of genome editing to investigate male reproductive mechanisms using mouse models.

Authors:  Samantha A M Young; R John Aitken; Masahito Ikawa
Journal:  Asian J Androl       Date:  2015 Jul-Aug       Impact factor: 3.285

4.  CRISPR/Cas9-based genome editing in mice uncovers 13 testis- or epididymis-enriched genes individually dispensable for male reproduction†.

Authors:  Jiang Sun; Yonggang Lu; Kaori Nozawa; Zoulan Xu; Akane Morohoshi; Julio M Castaneda; Taichi Noda; Haruhiko Miyata; Ferheen Abbasi; Hossam H Shawki; Satoru Takahashi; Darius J Devlin; Zhifeng Yu; Ryan M Matzuk; Thomas X Garcia; Martin M Matzuk; Masahito Ikawa
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.285

Review 5.  Toward Development of the Male Pill: A Decade of Potential Non-hormonal Contraceptive Targets.

Authors:  Katarzyna Kent; Madelaine Johnston; Natasha Strump; Thomas X Garcia
Journal:  Front Cell Dev Biol       Date:  2020-02-26

6.  Discovering in vitro spermatogenesis stimulating factors.

Authors:  J Chaudhary; F K Hamra
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

Review 7.  Animal models of contraception: utility and limitations.

Authors:  Emma R Liechty; Ingrid L Bergin; Jason D Bell
Journal:  Open Access J Contracept       Date:  2015-04-17

8.  Large-scale discovery of male reproductive tract-specific genes through analysis of RNA-seq datasets.

Authors:  Matthew J Robertson; Katarzyna Kent; Nathan Tharp; Kaori Nozawa; Laura Dean; Michelle Mathew; Sandra L Grimm; Zhifeng Yu; Christine Légaré; Yoshitaka Fujihara; Masahito Ikawa; Robert Sullivan; Cristian Coarfa; Martin M Matzuk; Thomas X Garcia
Journal:  BMC Biol       Date:  2020-08-19       Impact factor: 7.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.